Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v7-EN
Language French English
Date Updated 2020-04-02 2019-01-16
Drug Identification Number 02406446 02406446
Brand name PMS-TOPOTECAN PMS-TOPOTECAN
Common or Proper name Topotecan Topotecan
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients TOPOTECAN TOPOTECAN
Strength(s) 4MG 4MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 1
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2015-07-20 2015-07-20
Estimated end date Unknown Unknown
Actual end date 2020-04-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product to be discontinued Product will be deactivated
Health Canada comments